Nandhini R, Nath Banashree, Gaikwad Harsha S, Sharma Manjula, Meena Snehlata
Department of Obstetrics and Gynaecology, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India.
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India.
J Midlife Health. 2022 Oct-Dec;13(4):310-316. doi: 10.4103/jmh.jmh_38_22. Epub 2023 Apr 28.
This study aims to determine the prevalence of Metabolic Syndrome (MS) and recognize its abnormal components in pre and postmenopausal women. We also aim to recognize the abnormal components in postmenopausal women with regard to duration since menopause.
The cross-sectional study was undertaken among pre- and post-menopausal women between 40 and 65 years. Women with MS were identified as per the modified National Cholesterol Education Program Adult Treatment Panel III.
A total of 220 women were enrolled comprising 112 premenopausal and 108 postmenopausal women, the prevalence of MS among them being 33% and 51.85%, respectively. Postmenopausal status was found to be independently associated with MS when adjusted for potential confounders (adjusted odds ratios = 14.77, 95% confidence intervals: 1.77-23.33). All the components were proportionately higher in postmenopausal group, the rise in blood pressure (BP) ( = 0.003) and low high-density lipoprotein (HDL) (0.027) being statistically significant. The risk of MS, abdominal obesity, and high BP were highest in <5 years since menopause and decreased thereafter. The risk for low HDL and high triglyceride increased with the number of years since menopause, reaching the peak level in the 5-9-year group and then decreased while the risk of high fasting blood sugar increased reaching peak in the 10-14 years' group.
The prevalence of MS is significantly high in postmenopausal women. Screening of women in premenopausal period will give an opportunity to intervene and prevent the menace of MS in Indian women predisposed to abdominal obesity, insulin resistance, and cardiovascular adverse events.
本研究旨在确定绝经前和绝经后女性代谢综合征(MS)的患病率,并识别其异常组分。我们还旨在识别绝经后女性中与绝经时间相关的异常组分。
本横断面研究在40至65岁的绝经前和绝经后女性中进行。根据修改后的美国国家胆固醇教育计划成人治疗小组第三次报告确定患有MS的女性。
共纳入220名女性,其中112名绝经前女性和108名绝经后女性,她们中MS的患病率分别为33%和51.85%。在对潜在混杂因素进行校正后,发现绝经后状态与MS独立相关(校正比值比=14.77,95%置信区间:1.77-23.33)。绝经后组所有组分的比例均较高,血压(BP)升高(P=0.003)和高密度脂蛋白(HDL)降低(P=0.027)具有统计学意义。绝经后<5年时,MS、腹型肥胖和高血压的风险最高,此后降低。HDL降低和甘油三酯升高的风险随绝经年限增加而增加,在5-9年组达到峰值水平,然后降低,而空腹血糖升高的风险在10-14年组达到峰值。
绝经后女性中MS的患病率显著较高。对绝经前女性进行筛查将为干预和预防易患腹型肥胖、胰岛素抵抗和心血管不良事件的印度女性中的MS威胁提供机会。